logo
welcome
ABC News

ABC News

Ozempic producer CEO in hot seat in Senate hearing over cost of weight loss drug

ABC News
Summary
Nutrition label

77% Informative

Sen. Bernie Sanders grilled Novo Nordisk CEO Lars Jørgensen at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs.

The drugs have risen in popularity for diabetic patients and others looking to combat obesity since they were approved.

The CEO said the company was spending $30 billion to increase its production and access to the drugs.

The net price for Ozempic is still nearly $600 — over nine times as much as it costs in Germany .

The estimated net price of Wegovy is over $800nearly four and a half times the cost in Denmark .

Drug prices become a "pass through to the insurance companies" resulting in higher plan prices, Sanders said.

VR Score

80

Informative language

76

Neutral language

70

Article tone

informal

Language

English

Language complexity

43

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links